Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity

Giornale Italiano di Dermatologia e Venereologia

Volumn 151, Issue 1, 2016, Pages 37-43

  Chernyshov, Pavel V ^a  

^a BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Adult; Dermatitis, atopic; Psoriasis

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; ATOPIC DERMATITIS; CRONBACH ALPHA COEFFICIENT; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; FRUSTRATION; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PSORIASIS; QUALITY OF LIFE; SKINDEX 16; VALIDATION PROCESS; COMPLICATION; DERMATITIS, ATOPIC; HEALTH STATUS; PRURITUS; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

ADULT; DERMATITIS, ATOPIC; FEMALE; HEALTH STATUS; HUMANS; MALE; PRURITUS; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84971505260     PISSN: 03920488     EISSN: 18271820     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Langenbruch A, Radtke M, Franzke N, Ring J, Foelster-Holst R et al. Quality of health care of atopic eczema in Germany: results of the national health care study Atopic Health. J Eur Acad Dermatol Venereol 2013 [Epub ahead of print].
2. Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M. Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol 2010;24:989-1004.
3. Brenninkmeijer EE, Legierse CM, Sillevis Smitt JH, Last BF, Grootenhuis MA, Bos JD. The course of life of patients with childhood atopic dermatitis. Pediatr Dermatol 2009;26:14-22.
4. Ayala F, Sampogna F, Romano GV, Merolla R, Guida G, Gualberti G et al. The impact of psoriasis on work-related problems: a multicenter cross-sectional survey. J Eur Acad Dermatol Venereol 2013 [Epub ahead of print].
5. Holm EA, Esmann S, Jemec GB. The handicap caused by atopic dermatitis - sick leave and job avoidance. J Eur Acad Dermatol Venereol 2006;20:255-9.
6. Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol 2008;158:351-9.
7. Schmitt J, Heese E, Wozel G, Meurer M. Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - a prospective study. Dermatology 2007;214:68-76.
8. Evers AW, Lu Y, Duller P, van der Valk PG, Kraaimaat FW, van de Kerkhof PC. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 2005;152:1275-81.
9. Prinsen C, de Korte J, Augustin M, Sampogna F, Salek SS, Basra MK et al. Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life. J European Acad Dermatol Venereol 2013;27:1195-203.
10. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
11. Loo W-J, Diba V, Chawla M, Finlay AY. Dermatology Life Quality Index: influence of an illustrated version. Br J Dermatol 2003;148:285-90.
12. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035.
13. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996;107:707-13.
14. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433-40.
15. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16, A brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001;5:105-10.
16. Al Ghamdi KM, Al Shammari SA. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity. Int J Dermatol 2007;46:247-52.
17. Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren MM. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol 2002;29:693-8.
18. Chernyshov PV. Creation and cross-cultural adaptation of the Ukrainian versions of SKINDEX-29, SKINDEX-16 questionnaires, Psoriasis Disability Index and further validation of the Ukrainian version of the Dermatology Life Quality Index. Lik Sprava 2009;1-2:95-8.
19. Chernyshov PV, Bylaǐte M. Comparative study of quality of life in patients with psoriasis from Lithuania and Ukraine. Lik Sprava 2010;7-8:107-11.
20. Severity scoring of atopic dermatitis: the SCOR AD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
21. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
22. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part I. J European Acad Dermatol Venereol 2012;26:1045-60.
23. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011;303:1-10.
24. Hongbo Y, Thomas CL, Harrison MA, Salek M S, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005;125:659-64.
25. Chren M. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin 2012;30:231-6.
26. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 3rd ed. Oxford: Oxford University Press; 2003.
27. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000;80:430-4.
28. Schmid-Ott G, Burchard R, Niederauer HH, Lamprecht F, Künsebeck HW. Stigmatization and quality of life of patients with psoriasis and atopic dermatitis. Hautarzt 2003;54:852-7.
29. Twiss J, Meads DM, Preston EP, Crawford SR, McKenna SP. Can we rely on the dermatology life quality index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol 2012;132:76-84.
30. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999;141:1067-75.
31. Leibovici V, Canetti L, Yahalomi S, Cooper-Kazaz R, Bonne O, Ingber A et al. Well being, psychopathology and coping strategies in psoriasis compared with atopic dermatitis: a controlled study. J Eur Acad Dermatol Venereol 2010;24:897-903.
32. Hanifin GM, Rajka G. Diagnostic feature of atopic dermatitis. Acta Derm Venereol 1980;92:44-7.
33. Marks R. Topical therapy for psoriasis: general principles. Dermatologic Clinics 1984;2:383-8.
34. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
35. Evers AW, Lu Y, Duller P, van der Valk PG, Kraaimaat FW, van de Kerkhof PC. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 2005;152:1275-81.
36. O 'Neil J, Chan YH, Rap SR, Yosipovitch G. Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire. Acta Derm Venereol 2011;91:537-40.
37. Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005;152:289-95.
38. Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012;26(Suppl 3):61-7.
39. Franzke N, Montenbruck M, Langenbruch AK, Beikert FC, Kresken J, Augustin M. Drug supply for psoriasis - results from a national pharmacy network. J Dtsch Dermatol Ges 2013;11:638-43.
40. Torrelo A, Ortiz J, Alomar A, Ros S, Pedrosa E, Cuervo J. Healthrelated quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT Study. Actas Dermosifiliogr 2013;104:409-17.
41. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004;140:408-14.
42. Chan SA, Hussain F, Lawson LG, Ormerod AD. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J Dermatolog Treat 2013;24:64-9.
43. Schaarschmidt ML, Umar N, Schmieder A, Terris DD, Goebeler M, Goerdt S et al. Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol 2013;27:187-98.